A novel diagnostic method and therapeutic treatment of acute pulmonary inflammation
Researchersat OSU have discovered a novel antibody that could constitute a new therapeuticmethod to restrict the pathogenesis of ALI/ARDS. In a clinically relevantanimal model of ALI, a novel monoclonal antibody discovered by the researcherssignificantly inhibits neutrophil influx into alveolar space. Becauseneutrophil inflammation is central to development of ALI, this antibody mayprove to be the therapeutic agent that is greatly needed for ALI/ARDS patients.Moreover, this anitibody could be used as a novel diagnostic marker forALI/ARDS. This is critical because current diagnosis of ALI/ARDS is performedby the presence of non-cardiogenic pulmonary edema and respiratory failure,which are non-specific measures subject to inter-observer variability.
· Enables earlydetection of ALI/ARDS· Novel treatmentmethod to reduce severity of ALI/ARDS
· Quantitativediagnostic tool for ALI/ARDS· Method oftreatment for ALI/ARDS· Treatment forother inflammatory diseases, especially lung
None
美國
